9 results on '"M Guidotti"'
Search Results
2. Affective communities and millennial desires: Latinx, or why my computer won’t recognize Latina/o
- Author
-
Nicole M Guidotti-Hernández
- Subjects
Cultural Studies ,050402 sociology ,05 social sciences ,050301 education ,Gender studies ,Affect (psychology) ,Feminism ,Latina o ,0504 sociology ,Arts and Humanities (miscellaneous) ,Anthropology ,Queer ,Sociology ,0503 education - Abstract
There is a tremendous shift in public digital discourse and the academy more broadly, about the use of Latinx, one that may appear, on the surface, as an uncritical, hip way to shift how we talk about ourselves. While there is a long history of contestation about these categories of naming, my goal in this essay is to chart out the histories of how we went from using Mexican American and Puerto Rican to Chicano and Nuyorican and then the latest iterations, like Latina/o and eventually Latinx. By drawing on specific case studies of millennial digital cultures and the creation of new-phase ethnic studies departments in the 2000s, I demonstrate how millennials use Latinx to transcend gender, racial, class, and regional constraints they see emanating from boomer-generation ethno-nationalist formations. To be a part of the affective community represents a core value for millennials because it is antiessentialist because Latinx bears the load of recognition and diversity and represents the power of inclusion without speaking for everyone. Ultimately, Latinx can carry the excessive and diverse affective load of a population in ways that other ethno-nationalist and pan-Latina/o terms cannot.
- Published
- 2017
- Full Text
- View/download PDF
3. Symptom Validity Test Research: Status and Clinical Implications
- Author
-
Jerry J. Sweet and Leslie M. Guidotti Breting
- Subjects
business.industry ,Consensus conference ,Response bias ,medicine.disease ,Psychiatry and Mental health ,Clinical Psychology ,Empirical research ,Knowledge base ,Symptom validity test ,Malingering ,medicine ,business ,Psychology ,Clinical psychology - Abstract
This paper explores the extent of the knowledge base pertaining to symptom validity tests (SVTs), including empirical research studies, meta-analyses, position papers, and a consensus conference statement. We investigate publication outlets for research on symptom validity testing that have been published and identify the discipline of the authors. It is evident that the field of clinical psychology, and specifically neuropsychology, has amassed a very extensive research literature that has established the utility of SVTs in identifying insufficient effort on cognitive tests, response bias on symptom reporting inventories, and can be used to support or rule out malingering of psychological and neuropsychological conditions. This is particularly important for assessments that occur in a forensic context, but can also be important in routine clinical contexts and in relation to psychopathology. With the exception of not having full-fledged practice guidelines exclusively regarding SVTs, neuropsychologists and psychologists have all the guidance needed at present to be knowledgeable on the effective use and interpretation of SVTs.
- Published
- 2012
- Full Text
- View/download PDF
4. Symptom Validity Test Research: Status and Clinical Implications
- Author
-
Sweet, Jerry J., primary and Breting, Leslie M. Guidotti, additional
- Published
- 2012
- Full Text
- View/download PDF
5. Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis.
- Author
-
Gori AM, Giusti B, Piccardi B, Nencini P, Palumbo V, Nesi M, Nucera A, Pracucci G, Tonelli P, Innocenti E, Sereni A, Sticchi E, Toni D, Bovi P, Guidotti M, Tola MR, Consoli D, Micieli G, Tassi R, Orlandi G, Sessa M, Perini F, Delodovici ML, Zedde ML, Massaro F, Abbate R, and Inzitari D
- Subjects
- Aged, Biomarkers blood, Female, Humans, Logistic Models, Male, Multivariate Analysis, Predictive Value of Tests, ROC Curve, Stroke blood, Stroke mortality, Time Factors, Treatment Outcome, Cytokines blood, Metalloproteases blood, Stroke drug therapy, Thrombolytic Therapy
- Abstract
Inflammatory mediators and metalloproteinases are altered in acute ischemic stroke (AIS) and play a detrimental effect on clinical severity and hemorrhagic transformation of the ischemic brain lesion. Using data from the Italian multicenter observational MAGIC (MArker bioloGici nell'Ictus Cerebrale) Study, we evaluated the effect of inflammatory and metalloproteinases profiles on three-month functional outcome, hemorrhagic transformation and mortality in 327 patients with AIS treated with intravenous thrombolys in according to SITS-MOST (Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy) criteria. Circulating biomarkers were assessed at baseline and 24 h after thrombolysis. Adjusting for age, sex, baseline glycemia and National Institute of Health Stroke Scale, history of atrial fibrillation or congestive heart failure, and of inflammatory diseases or infections, baseline alpha-2macroglobulin (A2M), baseline serum amyloid protein (SAP) and pre-post tissue-plasminogen activator (tPA) variations (Δ) of metalloproteinase 9, remained significantly and independently associated with three-month death [OR (95% CI):A2M:2.99 (1.19-7.53); SAP:5.46 (1.64-18.74); Δmetalloproteinase 9:1.60 (1.12-2.27)]. The addition of baseline A2M and Δmetalloproteinase 9 or baseline SAP and Δmetalloproteinase 9 (model-2 or model-3) to clinical variables (model-1) significantly improved the area under curve for prediction of death [model-2 with A2M: p = 0.0205; model-3 with SAP: p = 0.001]. In conclusion, among AIS patients treated with thrombolysis, circulating A2M, SAP and Δmetalloproteinase 9 are independent markers of poor outcome. These results may prompt controlled clinical research about agents antagonizing their effect.
- Published
- 2017
- Full Text
- View/download PDF
6. Vesicoureteral reflux in pediatric age: where are we today?
- Author
-
Altobelli E, Gerocarni Nappo S, Guidotti M, and Caione P
- Subjects
- Adolescent, Child, Child, Preschool, Clinical Trials as Topic, Diagnostic Imaging methods, Disease Management, Female, Humans, Hydronephrosis diagnostic imaging, Hydronephrosis embryology, Hydronephrosis etiology, Incidence, Infant, Infant, Newborn, Kidney Failure, Chronic etiology, Male, Pregnancy, Prevalence, Severity of Illness Index, Ultrasonography, Prenatal, Urologic Surgical Procedures methods, Watchful Waiting, Young Adult, Vesico-Ureteral Reflux classification, Vesico-Ureteral Reflux complications, Vesico-Ureteral Reflux diagnosis, Vesico-Ureteral Reflux embryology, Vesico-Ureteral Reflux epidemiology, Vesico-Ureteral Reflux physiopathology, Vesico-Ureteral Reflux surgery
- Abstract
Although the diagnosis of vesicoureteral reflux and of reflux nephropathy is a well-established and shared procedure, its treatment nowadays is still very controversial. New developments on the knowledge of pathophysiology of renal damage associated to reflux opened the way towards a different diagnostic work-up and different therapeutic approaches. Recently, the "top-down" diagnostic approach has gained wider interest, versus the "down-top" protocol. The attention has recently focused on the renal parenchyma damage and less interest has been given to the presence and the radiological degree of vesicoureteral reflux. The review criteria were based on an in-depth search of references conducted on PubMed, using the terms "vesicoureteral reflux", "children", "incidence", "etiology", "diagnosis", "treatment" and "outcomes". The selection of the papers cited in this review was influenced by the content and the relevance to the points focused in the article.Conservative approaches include no treatment option with watchful waiting, long-term antibiotic prophylaxis and bladder rehabilitation. The operative treatment consists of endoscopic, open, laparoscopic and robotic procedures to stop the refluxing ureter.No final consensus has been achieved in literature yet, and further studies are necessary in order to better define the subset of children at risk of developing progression of renal damage.This review aims to clarify the diagnostic management and the urological-nephrological treatment of reflux in pediatric age, on the basis of a review of the best-published evidence.
- Published
- 2014
- Full Text
- View/download PDF
7. Stroke management in northern Lombardy: organization of an emergency-urgency network and development of a connection between prehospital and in-hospital settings.
- Author
-
Vidale S, Verrengia E, Gerardi F, Arnaboldi M, Bezzi G, Bono G, Guidotti M, Grampa G, Perrone P, Zarcone D, Zoli A, Beghi E, Agostoni E, Porazzi D, and Landriscina M
- Subjects
- Algorithms, Case-Control Studies, Clinical Protocols, Diffusion of Innovation, Emergency Medicine education, Hospitalization, Humans, Interprofessional Relations, Italy, Medical Staff, Hospital education, Prospective Studies, Thrombolytic Therapy standards, Emergency Medical Services organization & administration, Stroke therapy
- Abstract
Stroke is the leading cause of disability in adulthood, and the principal aim of care in cerebrovascular disease is the reduction of this negative outcome and mortality. Several studies demonstrated the efficacy of thrombolytic therapy in ischemic stroke, but up to 80% of cases could not be treated because the diagnostic workup exceeds the time limit. In this article, we described the design of a study conducted in the northern Lombardy, within the district of Sondrio, Lecco, Como, and Varese. The awaited results of this study are reduction of avoidable delay, organization of an operative stroke emergency network, and identification of highly specialized structures. The study schedules education and data registration with implementation and training of acute stroke management algorithms. The use of standardized protocols during prehospital and in-hospital phase can optimize acute stroke pathways. The results of this study could contribute to the assessment of an effective and homogeneous health system to manage acute stroke., (© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.)
- Published
- 2012
- Full Text
- View/download PDF
8. Trace copper(II) or zinc(II) ions drastically modify the aggregation behavior of amyloid-beta1-42: an AFM study.
- Author
-
Innocenti M, Salvietti E, Guidotti M, Casini A, Bellandi S, Foresti ML, Gabbiani C, Pozzi A, Zatta P, and Messori L
- Subjects
- Alzheimer Disease metabolism, Humans, Ions metabolism, Microscopy, Atomic Force, Amyloid beta-Peptides metabolism, Copper metabolism, Peptide Fragments metabolism, Zinc metabolism
- Abstract
Formation of amyloid-beta (Abeta){1-42} amyloid fibrils, a characteristic feature of Alzheimer's disease (AD), was monitored in situ through atomic force microscopy (AFM). Well-structured amyloid fibrils slowly formed in solution within 24 hours for which high quality AFM pictures could be obtained. Remarkably, addition of either copper(II) or zinc(II) ions to the incubation medium, even at extremely low molar ratios, dramatically changed the Abeta {1-42} aggregation profile and prevented fibril formation. Aggregates of different morphology appeared in accordance with previous observations: small globular aggregates upon addition of zinc; ill-structured micro-aggregates in the case of copper. The implications of these AFM results are discussed in the context of current concepts for AD metallobiology.
- Published
- 2010
- Full Text
- View/download PDF
9. Pirprofen in the treatment of migraine and episodic headache attacks: a placebo-controlled crossover clinical trial.
- Author
-
Guidotti M, Zanasi S, and Garagiola U
- Subjects
- Adult, Aged, Clinical Trials as Topic, Double-Blind Method, Female, Humans, Male, Middle Aged, Phenylpropionates adverse effects, Placebos, Random Allocation, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Headache drug therapy, Migraine Disorders drug therapy, Phenylpropionates therapeutic use
- Abstract
A double-blind, within patient, randomized study to compare the efficacy and tolerability of acute rectal administration of 600 mg pirprofen capsules with matched placebo was carried out in 40 out-patients. They were divided into two groups of 20 patients each according to diagnosis of episodic headache or common or classic migraine. Treatment was given once during each of two consecutive attacks according to a crossover design. None of the patients was withdrawn after randomization. There was a statistically significant difference in favour of pirprofen as regards the preferences expressed by patients at the end of the trial: 34 patients preferred pirprofen, two preferred placebo and four patients had no preference. Pirprofen significantly reduced the duration of headache attack and associated symptoms, but not the peak of pain intensity. Tolerability of the drug was good.
- Published
- 1989
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.